Med. praxi. 2025;22(4):264-268 | DOI: 10.36290/med.2025.056

Approach to the patient with dementia in primary care

MUDr. Eva Zatloukalová, Ph.D.
I. neurologická klinika FN u svaté Anny a LF MU, Brno

Dementia, defined as an acquired impairment of cognitive functions that limits patients' independence, represents a group of disorders with a steadily increasing prevalence. At the same time, both pharmacological and non-pharmacological options for symptomatic treatment are expanding. The aim of this review is to provide a concise and comprehensive overview of current recommended practices considering screening, diagnostics, therapeutic approaches and other important aspects of care.

Keywords: dementia, recommended practices, therapy.

Received: May 30, 2025; Revised: June 29, 2025; Accepted: July 4, 2025; Published: September 29, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zatloukalová E. Approach to the patient with dementia in primary care. Med. praxi. 2025;22(4):264-268. doi: 10.36290/med.2025.056.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Růžička E. Neurologie. 3. vyd. Praha: Triton; 2024. 712 s.
    2. Fiest KM, Jetté N, Roberts JI, Maxwell CJ, Smith EE, Black SE, et al. The Prevalence and Incidence of Dementia: a Systematic Review and Meta-analysis. Can J Neurol Sci. duben 2016;43 Suppl 1:S3-50. Go to original source...
    3. Mendez MF, Cummings JL. Dementia: a clinical approach [Internet]. 3rd ed. Philadelphia, PA : Butterworth-Heinemann; 2003. Available from: https://trove.nla.gov.au/version/45744865.
    4. Matějková A, Bartoš A, Býma S, et al. Doporučené diagnostické a terapeutické postupy pro všeobecné praktické lékaře - Demence (novelizace 2024) [Internet]. Centrum doporučených postupů pro praktické lékaře; 2024. Available from: https://www.svl.cz/doporucene-postupy/demence-100017
    5. Rusina R, Vaňková H. Alzheimerova nemoc a jiné kognitivní poruchy. MAXDORF; 2025. 38-40 s.
    6. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. duben 2005;53(4):695-9. Go to original source...
    7. Kopecek M, Stepankova H, Lukavsky J, et al. Montreal cognitive assessment (MoCA): Normative data for old and very old Czech adults. Appl Neuropsychol Adult. 2017;24(1):23-9. Go to original source...
    8. Bartoš A. Two original Czech tests for memory evaluation in three minutes - Amnesia Light and Brief Assessment (ALBA). Cesk Slov Neurol N. 2019;82/115(4):420-9. Go to original source...
    9. Bartoš A. Netestuj, ale POBAV - písemné záměrné Pojmenování OBrázků A jejich Vybavení jako krátká kognitivní zkouška. Cesk Slov Neurol N. 2016;79(112/6):671-9.
    10. Bartoš A. Tři časy testu kreslení hodin hodnocené BaJa skórováním u časné Alzheimerovy nemoci. Cesk Slov Neurol N. 2016;79(4):406-12.
    11. Jedlinská M. Funkční hodnocení seniorů, teorie a praxe. Geriatrie a Gerontologie. 2013;(3).
    12. Rusina R, Vaňková H. Alzheimerova nemoc a jiné kognitivní poruchy. MAXDORF; 2025. 98 s.
    13. Kurečková V, Trepáčová M, Zaoral A, Řezáč P, Zámečník P. Patří pacienti s demencí za volant? Geriatrie a Gerontologie. 2017;6(3):126-9.
    14. Bajtošová R, Holmerová I, Rusina R. Nové pohledy na léčbu demence. Neurologie pro praxi. 2021;22(3):194-200. Go to original source...
    15. Brodaty H, Donkin M. Family caregivers of people with dementia. Dialogues Clin Neurosci. červen 2009;11(2):217-28. Go to original source...
    16. Čolović MB, Krstić DZ, Lazarević-Pašti TD, et al. Acetylcholinesterase Inhibitors: Pharmacology and Toxicology. Curr Neuropharmacol. 2013;11(3):315-35. Go to original source...
    17. Yuan Q, Wang CW, Shi J, et al. Effects of Ginkgo biloba on dementia: An overview of systematic reviews. J Ethnopharmacol. 2017;195:1-9. Go to original source...
    18. Mayeux R, Sano M. Treatment of Alzheimer's Disease. New England Journal of Medicine. 1999;341(22):1670-9. Go to original source...
    19. Custodio N, Montesinos R, Lira D, Herrera-Pérez E, Bardales Y, Valeriano-Lorenzo L. Mixed dementia: A review of the evidence. Dement Neuropsychol. 2017;11(4):364-70. Go to original source...
    20. Breteler MM, van den Ouweland FA, Grobbee DE, Hofman A. A community-based study of dementia: the Rotterdam Elderly Study. Neuroepidemiology. 1992;11 Suppl 1:23-8. Go to original source...
    21. Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2000;21(1):49-55. Go to original source...
    22. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347(9009):1141-5. Go to original source...
    23. Chakraborty S, Lennon JC, Malkaram SA, Zeng Y, Fisher DW, Dong H. Serotonergic system, cognition, and BPSD in Alzheimer's disease. Neuroscience Letters. 2019;704:36-44. Go to original source...
    24. Uhrová T, Roth J. Neuropsychiatrie. 1. vyd. 2020. 976 s.
    25. Lebert F, Stekke W, Hasenbroekx C, Pasquier F. Frontotemporal dementia: a randomised, controlled trial with trazodone. Dement Geriatr Cogn Disord. 2004;17(4):355-9. Go to original source...
    26. Vališ M, Masopust J, Pavelek Z. Farmakoterapie nealzheimerovských typů demencí. Neurologie pro praxi. 2020;21(1):41-5. Go to original source...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.